Pharma-Bio Serv Announces Full Year Results and Special Dividend

Core Viewpoint - Pharma-Bio Serv, Inc. reported a revenue of approximately $9.0 million for the year ended October 31, 2025, reflecting a decrease of about $0.5 million compared to the previous year, while also showing a net loss improvement of approximately $0.7 million year-over-year [1][1][1] Financial Performance - Revenues for the year ended October 31, 2025, were approximately $9.0 million, down from the previous year [1] - The net loss for the same period was approximately $0.1 million, which is an improvement of approximately $0.7 million compared to the last year [1]